• {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%subBrandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%productMenuItems%}
    • {%selfProduct%}
      • {%languages%}
    • This website is for UK Healthcare Professionals only

      Watch the Clear Horizons TV AD Episode:

      Latest updates in care in Atopic Dermatitis

      Dr Laura Savage

      Consultant Dermatologist at Leeds Teaching Hospitals NHS Trust, with a special interest in Medical Dermatology and Honorary Senior Lecturer, Faculty of Medicine and Health, University of Leeds

      Dr Andrew Pink

      Consultant Dermatologist and Director of the adult Clinical Trials Unit at St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospitals, London

      Dr Sandy McBride

      Consultant Dermatologist, Royal Free London NHS Foundation Trust

      Professor Richard Warren

      Consultant Dermatologist in Manchester, Academic Vice President of the British Association of Dermatologists and Lead for Early Phase trial research across the Northern Care Alliance in Greater Manchester

      Dr Amy Foulkes

      Consultant Dermatologist at Salford Royal NHS Foundation Trust and an Honorary Senior Clinical Lecturer at the University of Manchester

      1. RINVOQ Summary of Product Characteristics

      UK-RNQD-210310. Date of preparation: March 2022

      Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.
      Adverse events should also be reported to AbbVie on GBPV@abbvie.com